GlaxoSmithKline Latvia (local operating company of the global GSK group) is one of the leading international science-led healthcare companies in Latvia, operating in Latvian market for more than 20 years.
In Latvia, GlaxoSmithKline aim to understand local needs and healthcare opportunities, and bring the best of the world-wide GSK knowledge, capability and relevant innovation to local patients to help them do more, feel better and live longer.
GlaxoSmithKline commercial success depends on not only bringing new medicines, vaccines and healthcare products to Latvia, but also making these accessible to as many people who need them as possible. By doing this, they provide benefits to patients, consumers, society, their employees and shareholders.
GlaxoSmithKline are one of the leading providers of vaccines (both adult and children) to Latvian market, but the main therapy areas they are working in are respiratory and HIV/AIDS.
GSK monitors email communications sent to and from GSK in order to protect GSK, our employees, customers, suppliers and business partners, from cyber threats and loss of GSK Information. GSK monitoring is conducted with appropriate confidentiality controls and in accordance with local laws and after appropriate consultation.